Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Bafna Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Outcome of AGM
Sub: Regulation 44(3) of the SEBI (Listing Operations and Disclosure Requirements) Regulations, 2015 - Scrutinizer Report of 23rd Annual General Meeting of the Company held on 29.09.2018 With reference to the above mentioned subject we hereby attach the voting Results under the Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Scrutinizer Report 23rd Annual General Meeting of the... Shareholder Meeting / Postal Ballot-Outcome of AGM
SUMMARY OF THE PROCEEDINGS OF THE 23RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER 2018 Fixes Book Closure for AGM (e-voting)
Bafna Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2018 to September 29, 2018 (both days inclusive) for the purpose of 23rd Annual General Meeting (AGM) of the Company to be held on September 29, 2018. Annual General Meeting
1. Annual General Meeting: The 23rd AGM of the Company is scheduled to be held on Saturday, the 29th of September, 2018, at 10.00 A.M 2. Book Closure: BSE Security Code NSE Symbol Type of Security Book closure (both days inclusive) Cut off date purpose from To 532989 BAFNAPHARM Equity 23-09-2018 29-09-2018 22-09-2018 Annual General Meeting... Outcome of Board Meeting
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that, the Board of Directors of the Company in its meeting held on today i.e 05th September , 2018, inter alia transacted the following: 1. Annual General Meeting: The 23rd AGM of the Company is scheduled to be held on Saturday, the 29th of September, 2018, at 10.00 A.M... Board Meeting Intimation for Approval Of Directors Report
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2018 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, 05th September 2018 at 3.00 P.M at the registered office of the Company, to inter alia consider and approve Director's Report for the year ending 31st March 2018, fixation of date... Outcome of Board Meeting
We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the quarter ending 30th June 2018. Please find attached the un-audited financial results for the first quarter ending 30th June 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. The meeting commenced at 7.30 PM and concluded at 8.30 PM Board Meeting Intimation for Result And Other Business
BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, 13th Aug 2018 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 30th June 2018 and any other business with the permission of the Chair. Shareholding for the Period Ended June 30, 2018
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here